18 May 2013
Keywords: filing, supplement, albuterol, anda, medeva, reported, its
Article | 20 March 1995
Medeva reported at its annual results presentation in London that
clinical studies for its generic albuterol metered-dose inhaler (MDI)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 March 1995
27 March 1995
17 May 2013
© 2013 thepharmaletter.com